Brief: Tongfang Kontafarma updates on lawsuit involving co's MD
Sept 15 (Reuters) - Tongfang Kontafarma 1312.HK
* Refers to petition involving co's MD in his capacity as
former non-executive director of China Shanshui Cement
* Derivative action is not in relation to group nor in
connection with performance of duties by Ng to group
Source text (http://bit.ly/2wusQge)
Further company coverage: 1312.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr